TradingView
BrianClow
Feb 10, 2021 9:35 PM

Recently approved for NASDAQ Long

Description

These guys develop cancer treatments and have had some good developments lately. Recently they were approved to be listed on the NASDAQ and should be happening very soon. Keep in mind there will be a reverse stock split between 5-20. I am guessing around 10 to get the price in the range for the NASDAQ. Upon news of that approval, stock broke from a bullish triangle. Long on this stock.
More